Skip to main content

Table 1 DLEU2 expression associated with the clinicopathological parameters in GC

From: lncRNA DLEU2 promotes gastric cancer progression through ETS2 via targeting miR-30a-5p

Clinicopathological parameters n DLEU2 expression P
Gender
 Male 55 1.437 ± 0.0617 0.5541
 Female 20 1.500 ± 0.0764
Age (years)
 < 60 33 1.507 ± 0.0731 0.8911
 ≥ 60 42 1.493 ± 0.0549
Tumor diameter (cm)
 < 5 31 1.473 ± 0.0727 0.1748
 ≥ 5 44 1.623 ± 0.0549
Pathological grading
 I–II 23 1.406 ± 0.0632 0.0087*
 III–IV 52 2.067 ± 0.1004
TNM staging
 T1–T2 15 1.997 ± 0.1695 0.0382*
 T3–T4 60 1.417 ± 0.0869
  1. *P < 0.05